These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23489659)

  • 1. Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.
    Sun P; Peng X; Sun S; Novick D; Faries DE; Andrews JS; Wohlreich MM; Wu A
    Pain Pract; 2014 Jan; 14(1):22-31. PubMed ID: 23489659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
    Zhao Y; Sun P; Watson P; Mitchell B; Swindle R
    Pain Pract; 2011; 11(3):204-16. PubMed ID: 20807351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Jan; 12(1):14-22. PubMed ID: 21615857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
    Sun P; Zhao Y; Zhao Z; Watson P
    Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
    Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
    Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
    Pain Med; 2014 Aug; 15(8):1282-93. PubMed ID: 24401017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
    Marlow NM; Simpson KN; Vaughn IA; Jo A; Zoller JS; Short EB
    Pain Pract; 2018 Feb; 18(2):154-169. PubMed ID: 28419725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
    Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
    Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine.
    Zhao Y; Chen SY; Wu N; Fraser KA; Boulanger L
    Pain Pract; 2011; 11(4):381-91. PubMed ID: 21199311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin.
    Gore M; Sadosky AB; Zlateva G; Clauw DJ
    Pain Pract; 2009; 9(5):363-74. PubMed ID: 19500273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.
    Peng X; Sun P; Novick D; Andrews J; Sun S
    J Pain Res; 2014; 7():37-46. PubMed ID: 24470771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressants.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):32-44. PubMed ID: 21970698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.
    Udall M; Mardekian J; Cabrera J
    Pain Pract; 2013 Jul; 13(6):476-84. PubMed ID: 23150918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care.
    Kleinman NL; Sanchez RJ; Lynch WD; Cappelleri JC; Beren IA; Joshi AV
    Pain Pract; 2011; 11(6):540-51. PubMed ID: 21392253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.
    Udall M; Louder A; Suehs BT; Cappelleri JC; Joshi AV; Patel NC
    J Med Econ; 2013; 16(6):784-92. PubMed ID: 23565813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
    Kim SC; Landon JE; Lee YC
    Arthritis Res Ther; 2015 Jan; 17(1):18. PubMed ID: 25627453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of duloxetine and celecoxib in osteoarthritis patients.
    Peng X; Wu N; Chen SY; Yu X; Andrews JS; Novick D
    Curr Med Res Opin; 2013 Sep; 29(9):1161-9. PubMed ID: 23777314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.